โ ViewAdvancedIndustry Deep Dives โบ Healthcare & Pharma
Radiopharma M&A: Why Big Pharma is Betting Big on Precision Medicine
The recent $1.65 billion acquisition of ITM by Telix highlights a growing trend in the pharmaceutical sector: the aggressive pursuit of radiopharmaceutical assets. This niche, yet high-growth, field is attracting significant capital as companies look to secure next-generation cancer treatment technologies.
1mยท๐ 0
โ ViewAdvancedIndustry Deep Dives โบ Technology & Software
AbbVie Secures European Approval for Pediatric Arthritis Drug
AbbVie announced that the European Commission has approved RINVOQ for the treatment of children aged two and older with active polyarticular juvenile idiopathic arthritis. This incremental approval is a critical mechanism for extending patent exclusivity and maintaining long-term dominance in the immunology space.
1mยท๐ 0
โ ViewAdvancedIndustry Deep Dives โบ Healthcare & Pharma
Healthcare and Pharma Pivot Amid Regulatory Changes
The global healthcare industry is navigating a tighter regulatory environment that is reshaping how companies approach drug development and market access. Strategic partnerships are becoming the primary tool for firms to share risk and maintain innovation in key medical fields.
2mยท๐ 0
โ ViewAdvancedGeopolitics & Defense โบ War & Conflict
Roivant Sciences Advances Pulmonary Hypertension Pipeline with Positive Phase 2 PHocus Results
Roivant Sciences announced positive topline results from its Phase 2 PHocus study evaluating inhaled mosliciguat for pulmonary hypertension associated with interstitial lung disease. The study met its primary endpoints by significantly lowering pulmonary vascular resistance, paving the path toward pivotal Phase 3 trials. This clinical progress highlights the drug's potential in a major underserved therapeutic market.
2mยท๐ 0
โ ExplanationAdvancedIndustry Deep Dives โบ Healthcare & Pharma
Gland Pharma's USFDA Milestone: A Quality Signal
Gland Pharma has successfully cleared a USFDA inspection with zero observations, a significant achievement that underscores the company's commitment to manufacturing quality. This regulatory success is a positive catalyst for the company's expansion plans in the U.S. market.
1mยท๐ 0
โ ExplanationUnderstandingCountry Profiles โบ Country Profiles
Bangladesh: Economic Future โ Pharma, Digital Bangladesh, and the Climate Threat
Bangladesh stands at a critical juncture as rapid export-led industrialization and digital expansion confront mounting macroeconomic pressures and severe climate risks. Sustaining long-term growth requires industrial diversification, banking sector stabilization, and strategic adaptation to prepare for the loss of trade preferences following graduation from Least Developed Country status.
10mยท๐ 1